The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

Obesity and asthma are both serious health problems that many people in the U.S. face. Unfortunately, many people have to ...

Patients with asthma who completed weekly symptom questionnaires and viewed educational information saw greater QoL improvements.

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Air pollution, built environment, and ambient temperature jointly contribute to incident asthma risk, according to a recent study.

Asthma + Lung UK found around two-thirds of sufferers find poor air quality makes their asthma worse. The NHS's advice webpage states: 'Symptoms happen when your airways become swollen.

Cleaner, better-thought-out cities could ward off 1 of every 10 asthma cases, researchers reported recently in The Lancet ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in ...

Patients with systemic sclerosis or Sjögren's syndrome suffer from various inflammatory reactions triggered by the body's own ...

GSK)’s asthma medication, Nucala, for expanded use in treating a form of chronic obstructive pulmonary disease (COPD), often referred to as “smoker’s lung,” the company announced Thursday.

Stronger stress responses in threat-sensitive brain regions were associated with greater allergen-induced inflammatory ...